Recent research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has shed light on the survival benefits of anatomic lung resections, specifically lobectomy and segmentectomy, for patients diagnosed with stage 1A non-small cell lung cancer (NSCLC). Utilizing data from the STS
The transformative potential of Artificial Intelligence (AI) in the field of therapeutics, particularly drug development, has been a topic of significant excitement and investment. However, despite the enthusiasm, tangible evidence of AI's success in revolutionizing drug development remains
A recent study has unveiled a new type of stem cell in the brain that could potentially revolutionize treatments for adult glioblastoma (GBM), a highly lethal brain tumor. Conducted by a team led by Li Wang and guided by senior author Arnold Kriegstein at the University of California, San Francisco
Imagine a world where obesity is not just a physical health challenge but a severe risk factor for life-threatening diseases. The increasing prevalence of obesity in modern society has become a significant concern for public health experts, especially with the stark rise in cancer cases. Delving
The integration of CRISPR technology with biomaterials engineering offers a promising avenue for safer and more effective gene therapies. Tomas Gonzalez-Fernandez, an assistant professor at Lehigh University, has received funding from the National Science Foundation’s Faculty Early Career D
In a groundbreaking study, researchers have introduced a non-invasive method to predict stroke risk using a 'vascular fingerprint' identified in the retina, suggesting revolutionary potential for medical diagnostics. The method is detailed in the journal Heart, demonstrating that retinal
Aspect Biosystems, a pioneer in the field of bioprinted tissue therapeutics, recently closed a $115 million Series B financing round aimed at advancing its groundbreaking technology in regenerative medicine. This achievement, led by Dimension and supported by investors such as Novo Nordisk and
As the new year begins, NHS workers continue to face significant pressures and challenges during the winter months, with patient safety concerns becoming more pronounced across various facets of the healthcare system. Several acute trusts have declared critical incidents due to winter pressures,
The biotech industry in particular will experience high levels of uncertainty and changes in 2025. Emerging biotech companies are facing significant challenges due to new technologies, intense global competition, and changes in the market. Next year, 2025, may be tough for startups as they
Navigating the complexities of critical care clinical trials, particularly when facing the issue of "truncation due to death," is crucial for obtaining unbiased, clear, and meaningful results. Patient-centered outcomes affected by death before they can be fully measured pose significant
